Breaking News, Financial News

Financial Report: INC Research

Revenues up 14% in the quarter

INC Research
 
2Q Revenues: $227.4 million (+14%)

2Q Earnings: $23.3 million (+53%)

YTD Revenues: $438.9 million (+13%)

YTD Earnings: $48.6 million (earnings were $13.8 million YTD14)

Comments: Backlog grew by 12% year-over-year to $1.7 billion as of June 30, 2015. Service revenue growth during both the quarter and first half was primarily driven by continued strong awards over the last two years, a lower cancellation rate of previously awarded business and a positive revenue mix. In 2015, revenue grew across all therapeutic areas and has been particularly strong in the CNS, Oncology and other complex therapeutic areas.  

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters